It has been reported that knocking out Eno1 significantly decreases tumor growth in mouse models (36) and that administering anti-ENO1 mAb inhibits the invasiveness of pancreatic cancer cells (37). This evidence concerns the gene ENO1 and pancreatic neoplasm.